Protein Molecular Characteristics and Prognosis of Cervical Neuroendocrine Tumors

Launched by FUJIAN MATERNITY AND CHILD HEALTH HOSPITAL · Feb 21, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on understanding cervical neuroendocrine tumors, a type of cervical cancer. Researchers are collecting and analyzing data from 300 women who have been diagnosed with this condition. They will look at various health records, including biopsy results, to learn more about the characteristics of these tumors and how they might affect a patient's prognosis, which means the likely outcome or chance of recovery. Additionally, they are gathering tissue samples from 100 patients to study the proteins involved in these tumors, hoping to find valuable information that could help in treatment decisions in the future.

To be eligible for this trial, participants need to be women diagnosed with cervical neuroendocrine carcinoma through a tissue examination. They also need to have complete medical data and be treated at the participating hospital. Unfortunately, those who cannot provide follow-up information, refuse to participate, or have poor-quality tissue samples will not be included. For participants, this trial offers an opportunity to contribute to important research that could improve understanding and treatment of this rare type of cancer.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients diagnosed with cervical neuroendocrine carcinoma by histopathology
• • 2. Clinical data were complete
• Exclusion Criteria:
• • 1. Patients who are not being treated in our hospital
• • 2. Patients with lack of follow-up data, unable to obtain survival information
• • 3. Patients call to refuse to participate in this project
• • 4. The quality of paraffin specimens can not meet the requirements of proteome concentration determination